MCL

In November 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

Understanding the difference between benign and malignant adrenal tumors has always been difficult, but the new Urinary Steroid Profile assay will assist with this medical challenge.

Due to the Thanksgiving holiday in the United States (recognized on Thursday, Nov. 28), the Mayo Clinic Laboratories specimen pickup and delivery schedule will be altered. To ensure that your specimen vitality and turnaround time are not affected, plan ahead and note that no pickups or deliveries will be made on November 28 by our couriers or FedEx.

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for herpes simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of America, to avoid using this test for clinical decision making purposes. As a result of these recommendations and data generated at Mayo Clinic, Dr. Theel will summarize why HSV IgM testing will no longer be offered through Mayo Clinic Laboratories.

In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

This week's featured chromosomal microarray test in focus is presented by William Sukov, M.D., a pathologist and cancer geneticist at Mayo Clinic. He discusses when this test should be used for patients with renal tumors.

Hear advice firsthand from William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, as he tells stories that helped shape his journey in laboratory medicine.

In this month’s “Hot Topic,” Jessie Swanson and Michelle Soland from the Component Laboratory will discuss the process improvement that helped decrease the standard cryoprecipitate dosage and the positive impact it has on patients.

In September 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes. In addition to these new tests, the department also announced several test changes.

The “Reject Due To” information contained in our online test catalog is being updated to provide greater clarity around rejection standards.

In August 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

The Mayo Clinic Laboratories Education team recently announced the launch of a new educational podcast titled “Lab Medicine Rounds.” Lab Medicine Rounds is a curated podcast for physicians, laboratory professionals, and students that covers a wide variety of laboratory medicine-related topics.

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections.